Peptilogics
PITTSBURGH, PA · Founded 2013 · CIK 0001663983 · Biotech · Private
Peptide-based coatings and surface treatments for medical devices to prevent biofilm formation and infection
peptilogics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $41M
- 4 Form D · Dec 2020
- 69 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 24
- 4 granted · 20 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $416,761 | |
| Private capital raised | Form D · SEC | $753,999 | |
| Private capital raised | Form D · SEC | $4,000,000 | |
| Private capital raised | Form D · SEC | $35,777,098 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1445 | TRAILHEAD BIOSYSTEMS, INC. | — | $30M |
| 1446 | Saliogen Therapeutics, Inc. | — | $94M |
| 1447 | BRAINSTORM THERAPEUTICS, INC. | — | — |
| 1448 | Peptilogics | — | $41M |
| 1449 | Thetis Pharmaceuticals LLC | — | $14M |
| 1450 | PANDOMEDX, INC. | — | — |
| 1451 | COMETA THERAPEUTICS INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jason CammDirector
- Stephan DietrichDirector
- Hannes HolsteDirector
- Sanjay KakkarDirector · Executive Officer
- Catherine MottDirector
- Stefan RoeverDirector
- Jonathan SteckbeckDirector · Executive Officer
- Dietrich StephanDirector
Patents
- Artificial Intelligence Engine Architecture For Generating Candidate Drugsapplication
- Generating Anti-infective Design Spaces For Selecting Drug Candidatesapplication
- Generating Enhanced Graphical User Interfaces For Presentation Of Anti-infective Design Spaces For Selecting Drug Candidatesgranted
- Engineered Antimicrobial Amphiphilic Peptides And Methods Of Useapplication
- Engineered Antimicrobial Peptides And Usage Thereofapplication
- Generating Enhanced Graphical User Interfaces For Presentation Of Anti-infective Design Spaces For Selecting Drug Candidatesapplication
- Methods And Apparatuses For Generating Peptides By Synthesizing A Portion Of A Design Space To Identify Peptides Having Non-canonical Amino Acidsapplication
- Engineered Antimicrobial Peptides and Usage Thereofapplication
- Generating Anti-infective Design Spaces For Selecting Drug Candidatesgranted
- Engineered Antimicrobial Peptides And Usage Thereofapplication
- Generating Enhanced Graphical User Interfaces For Presentation Of Anti-infective Design Spaces For Selecting Drug Candidatesgranted
- Intravenous Administration Of Engineered Antimicrobial Amphiphilic Peptidesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.